Stay updated on DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.

Latest updates to the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedLocations section added with study sites across California, Georgia, New York, Oregon, Pennsylvania, Texas, Alberta, Ontario, and Quebec. Page revision updated to v3.3.3.SummaryDifference1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision history shows a new v3.3.2 revision added and v3.3.1 removed, indicating a minor page update. The study content, inclusion criteria, and results have not changed.SummaryDifference0.1%

- Check36 days agoChange DetectedPage shows a minor version update from v3.2.0 to v3.3.1 with no changes to study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe government funding/operating status notice has been removed from the page; the rest of the study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedThe new screenshot shows only minor UI and layout adjustments (e.g., updated header area and spacing) with no changes to the study's details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check87 days agoChange DetectedAdded a prominent government-operating status notice and new version tag (v3.2.0), while removing the old v3.1.0 revision. The page now informs users about potential delays and where to check status.SummaryDifference5%

Stay in the know with updates to DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.